Table 3.

The individual and average PCL and CAPS scores determined before the initiation of treatment (pre-study) and at clinical relapse (relapse); where DR represents a patient who did not return for clinical assessment, # represents a significant difference between pre-study and 24 h scores with p < 0.0001 (paired t-test) and * represents a significant difference between pre-study and relapse scores with p < 0.0001 (paired t-test).

Patient	PCL Pre-study	PCL 24 h	PCL Relapse	CAPS Pre-study	CAPS 24 h	CAPS Relapse
1	76	25	67	95	12	62
2	77	36	65	86	38	68
3	80	32	64	84	19	66
4	82	25	52	92	16	58
5	76	28	55	96	26	72
6	77	17	71	81	16	52
7	60	31	57	72	18	54
8	81	22	68	97	26	72
9	81	24	69	95	16	68
10	62	21	57	86	19	54
11	60	22	66	74	10	64
12	66	36	DR	82	39	DR
13	75	18	52	96	16	52
14	75	26	56	98	28	56
15	75	28	56	93	27	56
16	70	21	55	92	18	55
17	67	29	52	83	26	52
18	78	17	54	89	18	54
19	76	18	64	94	16	64
20	67	45	58	92	48	58
Average	73.4 ± 7.0	26.1 ± 7.3#	59.9 ± 6.4*	89.2 ± 7.6	22.6 ± 9.8#	63.1 ± 7.5*